Clinical Trials Directory

Trials / Unknown

UnknownNCT06089356

Zolmitriptane as Prophylaxis for Chilhood Migraine

Zolmitriptane as Prophylactic Therapy Childhood Migraine

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
8 Years – 18 Years
Healthy volunteers
Not accepted

Summary

zolmitriptane can be tried as prophylactic therapy of childhood migraine

Detailed description

90 children with migraine included in the study first group 30 received zolmitriptane second group 30 received topiramate third group 30 received valproate

Conditions

Interventions

TypeNameDescription
DRUGzolmitriptaneezolmitriptane tablet daily
DRUGtopiramatetopiramate once daily
DRUGValproatevalproate once daily

Timeline

Start date
2023-01-01
Primary completion
2024-01-01
Completion
2024-01-01
First posted
2023-10-18
Last updated
2023-10-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06089356. Inclusion in this directory is not an endorsement.